IP Library Granted Patent US 11,752,235
Granted Patent B2
US 11,752,235 · App. 16/325,658 · Granted Sep 12, 2023

Collagen/ORC dressing encapsulated within a bioresorbable envelope

Inventors: Craig Delury (Gargrave, GB); Alexander Waite (Keighley, GB)
Assignee: KCI Licensing, Inc.
A61L15/64A61F13/00012A61F13/00017A61F13/15252A61F13/539A61L15/28A61L15/32A61L15/325A61L15/425A61L15/44A61L26/0009A61L26/0085A61F2013/00221A61F2013/15878A61F2013/51147A61F2013/530802
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,752,235
App. No.
16/325,658
Granted
Sep 12, 2023
Kind
B2
Abstract

Wound dressing compositions comprising of a bioresorbable sponge encapsulated within a polysaccharide envelope. The bioresorbable sponge is preferably comprised of collagen and oxidised regenerated cellulose. The outer polysaccharide envelope is preferably comprised of chitosan. The outer polysaccharide envelope functions to modulate the rate at which the bioresorbable sponge breaks down within a wound.

Claims (14)

1. A wound dressing comprising

a bioresorbable sponge having a wound-facing surface and an opposite bottom surface, the bioresorbable sponge comprising oxidized regenerated cellulose (ORC) and collagen; and

a bioresorbable top sheet covering the wound-facing surface of the bioresorbable sponge, the top sheet comprising a polysaccharide polymer, the top sheet further comprising a perforation density of about 4/cm 2 , and the perforations have an average diameter of from about 0.02 cm to about 0.4 cm.

2. The wound dressing according to claim 1 , wherein the polysaccharide polymer is selected from the group consisting of alginates, chitosan, chitin, guar gums, starch derivatives, cellulose derivatives, glycosaminoglycans, chondroitin sulfate, heparin sulfate, and a mixture of any two or more thereof.

3. The wound dressing according to claim 1 , wherein an aqueous solution used to generate the top sheet has a solids content of from about 1% wt./vol. to about 5% wt./vol.

4. The wound dressing according to claim 1 , further comprising a bottom sheet.

5. The wound dressing according to claim 4 , wherein the bottom sheet comprises a resorbable polysaccharide.

6. The wound dressing according to claim 4 , wherein the top sheet and the bottom sheet are bonded so as to substantially encapsulate the bioresorbable sponge.

7. The wound dressing according to claim 1 , wherein the bioresorbable sponge further comprises a structural protein.

8. The wound dressing according to claim 7 , wherein the structural protein is selected from the group consisting of fibronectin, gelatin, fibrin, laminin, elastin, and a mixture of any two or more thereof.

9. The wound dressing according to claim 7 , wherein the bioresorbable sponge comprises at least 75% of a mixture of the ORC and the structural protein by weight.

10. The wound dressing according to claim 1 , wherein the bioresorbable sponge comprises a mixture of ORC and collagen, wherein the mixture comprises from about 50% to about 60% collagen by weight.

11. The wound dressing according to claim 1 , wherein the bioresorbable sponge is substantially planar, having a width of from about 3 cm to about 30 cm, and a length of from about 3 cm to about 30 cm.

12. The wound dressing according to claim 1 , further comprising an antimicrobial agent selected from the group consisting of tetracyclines, beta-lactams, macrolides, aminoglycosides, fluoroquinolones, silver, silver salts, and a mixture of any two or more thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2022
From: WAITE, ALEXANDER; DELURY, CRAIG
To: KCI LICENSING, INC.
Reel/Frame 059265/0236 →
Continuity (2)
Provisional Application 62375696 · Aug 16, 2016
Related Publication 20190201574A1 · Jul 4, 2019